Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets

Stefan Wiemann(German Cancer Research Center), Ângela Gonçalves(German Cancer Research Center)
Research Square
May 25, 2023
10.21203/rs.3.rs-2813593/v1
Cited by 1

Related Papers

MicroRNA‐30c‐2‐3p negatively regulates NF‐κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer
|Molecular Oncology|2015|105
Integrating proteomics into precision oncology
|International Journal of Cancer|2020|30
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets
|npj Breast Cancer|2023|8